In ovarian cancer, increased infiltration of tumor-infiltrating lymphocytes (TILs), and more specifically CD8+ T cells, have been proven to be associated with improved clinical outcomes (Sato et al., 2005; Hamanishi et al., 2007; Ovarian Tumor Tissue Analysis et al., 2017). Here, CD8A is linked to neoplasm.